Earum Pharmaceuticals Rights Issue 

Earum Pharmaceuticals Rights Issue  will open for subscription from 02 May 2023. the company aims for an issue size of ₹49.34 Crores through this rights Issue.

About the company

Incorporated in 2012, Earum Pharmaceuticals Limited is engaged in the pharmaceutical business involving marketing, trading, and distribution of pharmaceutical formulation products. Earum Pharmaceuticals’ product range includes anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/antipyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections. Currently, the company has its presence in Indian States such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan, Madhya Pradesh, Manipur, Assam, Meghalaya, Kerala, Telangana, etc., and intends to penetrate international markets as well.

Objectives of the Issue

  • For working capital requirements.
  • Repayment of loan.
  • General corporate purposes.

Rights Issue Timetable

Last Date to buy shares06 April 2023
Record Date10 April 2023
Credit of Rights Entitlements26 April 2023
Bid/Offer Opens On02 May 2023
Renunciation of Rights Entitlements26 May 2023
Bid/Offer Closes On31 May 2023
Deemed Date of Allotment10 June 2023
Credit Date16 June 2023
Listing Date20 June 2023

Rights Issue Details

Issue OpenMay 2, 2023 – May 31, 2023
Security NameEarum Pharmaceuticals Limited
Issue Size (Shares)246,716,400
Issue Size (Amount)₹49.34 Crores
Issue Price₹2 per share
Face Value₹2 per share
Listing AtBSE
Terms of PaymentInvestors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call.
Entitlement4 Equity Shares for every 1 Equity Shares held on the Record Date

Company Financials

Period EndedTotal AssetsTotal RevenueProfit After TaxReserves and Surplus
(Amount in ₹ Crore)

Rights Issue Documents

Lead Manager(s)

  • Axis Bank Limited

Rights Issue Registrar

Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com

Company Contact Information

Earum Pharmaceuticals Limited
A-1106, Empire Business Hub,
Near AUDA Water Tank, Science City Road,
Sola, Ahmedabad – 380060

Phone: (079)-48402525
Email: cs@earumpharma.com

Final Thoughts

Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.

Happy investing

Leave a Comment

Your email address will not be published. Required fields are marked *